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ABSTRACT
The miR-290 cluster is expressed in embryonic stem
cells (ESCs) and is important for the maintenance
of pluripotency, but little is known about the mech-
anisms regulating the early embryonic microRNA
cluster (EEmiRC) expression. Here we report the
identification of a 332-bp intragenic enhancer (IE)
able to modulate the transcription of the mouse
EEmiRC locus, presumably through binding of
transcription modulators like Oct3/4, Sox2 and
CTCF. This IE also contains a CpG island showing
a differential pattern of DNA and histone methyla-
tion marks during differentiation of ESCs, which
places EEmiRC in a novel regulatory feedback loop
with DNA methylases. Deletion of IE significantly
reduced the transcription of the EEmiRC, further
proving the importance of this region in regulating
the expression of EEmiRC.
INTRODUCTION
Embryonic stem cells (ESCs) have the unique potential to
selfrenewanddifferentiateintoallthreegermlayers,which
involves coordinated changes in the balances between
multiple signaling pathways (1,2). This exquisitely
tight coordination involves regulation at the transcrip-
tional level as well as at the post-transcriptional level
through the action of small non-coding microRNAs
(miRs) (2,3). MicroRNAs are 22–25-nt-long genome-
encoded small RNAs able to post-transcriptionally
modulate gene expression by base-pairing to target sites
in the 30-UTR of mRNAs. Biogenesis of mature
microRNAs involves the obligatory generation of two
intermediates: pri-miRNA (long, polyadenylated, capped
transcript produced by PolII), which is further cleaved
by a microprocessor complex formed by DGCR8 and
Drosha to pre-microRNAs, short (60–70nt) stem-looped
transcripts exported into the cytoplasm by exportin-5.
Pre-microRNAs are recognized by a Dicer/TRBP/Ago
complex and further cleaved to mature 22–25-nt-long
microRNA duplexes. The leading strand of the mature
microRNA duplex is loaded onto the RNA-induced
silencing complex (RISC or miRISC) and heterodimerize
with complementary sequences in the 30-UTRs of target
mRNAs, thus serving as a guide for RISC repression (4).
The vast majority of the miRNAs are located within
introns (mostly in antisense orientation), in intergenic/
non-protein-coding regions or can be organized in
gene-like units, equipped with dedicated promoters
driving transcription of capped and poly-adenylated
pri-miRNAs (5). MicroRNA clusters are particularly
interesting given that the coordinated expression of an
entire set of mature microRNAs might theoretically
achieve the simultaneous modulation of the fate of
hundreds of mRNA targets.
A typical example of a microRNA gene is the early
embryonic microRNA cluster (EEmiRC) identiﬁed in
ESCs of placental mammals, and showing a remarkable
cross-eutherian species conservation at the levels of both
pre-miRNA hairpins and the core-promoter region (6,7).
EEmiRC encodes seven microRNAs (miR-290, -291a,
-292, -291b, -293, -294 and -295), which have been labeled
as ESC-speciﬁc/pluripotency-associated microRNAs
controlling cell-cycle progression, proliferation and DNA
methylation (8–10) in undifferentiated/pluripotent cells.
Therefore, understanding the biology of ESCs requires
the detailed knowledge of the mechanisms regulating
EEmRC expression.
Surprisingly little is known about this subject. High
through-put genome wide ChIP analysis showed that the
sequences upstream to the EEmiRC promoter contains
active binding sites for Nanog, Oct3/4, Sox2, Tcf3,
c-Myc and 4n-Myc, and is H3K4 trimethylated in ESCs
and H3K27 trimethylated in differentiated cells (2,11,12).
However, attempts to activate EEmiRC expression by
ectopic expression of these individual TFs in ﬁbroblasts
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expression is under epigenetic control (12). In this study,
we have identiﬁed within the EEmiRC a previously un-
covered region able to regulate the expression of miR290s,
which involves pluripotency factors and epigenetic mech-
anisms in pluripotent and differentiated cells.
MATERIALS AND METHODS
Cell culture and differentiation
Mouse ESCs, P19CL6 carcinoma cells, mouse embryonic
ﬁbroblasts (MEF) and HEK293T cells were cultured fol-
lowing standard procedures. ZHBTc4 ES cells were
described previously (13). Differentiation of ES cells into
neural progenitor cells was performed essentially as
described in ref. (14) with some modiﬁcations.
miRNA and RNA isolation and quantitative RT–PCR
miRNA and total RNA were isolated using miRVana
micro RNA isolation kit (Ambion). cDNA synthesis was
carried out using standard procedures. miRNA quantiﬁ-
cation was done using Taqman assays (Applied
biosystems).
Plasmids, transfection and reporter assays
All the reporter constructs were cloned into either pGL-
4.23 or pGL-4.23dMP plasmids. pEEmiRC plasmid was
described previously (7). Transfection of all reporter
plasmids, pEEmiRC-EGFP, pEEmiRC-dEn-II.1a-GFP
and pEEmiRC-dTATA-GFP constructs was performed
using Lipofectamine LTX reagent. Renilla luciferase
served as transfection control and luciferase activities
were represented as relative light units.
Bisulphite sequencing and in vitro methylation
Bisulﬁte sequencing was performed using the EZ methy-
lation kit (Zymo research). In vitro methylation of
pGL-4.23 empty vector and EnII.1a fragment containing
vector was done using M.SssI (New England Biolabs) and
the efﬁciency of in vitro methylation was checked using
methyl sensitive restriction enzyme HpaII.
Chromatin immunoprecipitation
Chromatin immunoprecipitations (ChIPs) were performed
as described previously (11). Brieﬂy, formaldehyde cross-
linked cells were lysed and sonicated to shear the DNA.
The sonicated DNA was pre cleared using agarose beads
and then immuno complexes were formed using respective
antibodies. The immuno complexes were collected using
protein A/G agarose beads and ﬁnally DNA was eluted.
The eluted DNA and 1% of respective input DNA was
reverse cross-linked and used for the qPCR using SYBR
Green qPCR mix with ROX (Fermentas).
Statistical analysis
All experiments were performed at least in triplicates.
Statistical signiﬁcance was tested using the t-test (paired,
two-tailed).
A detailed description of all materials and methods used
can be found in the Supplementary Text.
RESULTS
Transcriptional attenuation of EEmiRC during
differentiation
The EEmRC genomic locus is spread over 3.2kb on
chromosome 7 and is organized into two hemiclusters
(hC) separated by a stretch of 782nt: 50-hC (containing
pre-miR-290, -291a, -292 and -291b) and 30-hC (contain-
ing pre-miR-293, -294 and -295). Quantitative RT–PCR
analysis of EEmiRC mature microRNAs levels in ESCs
showed strong discrepancies between the expression levels
of the miR290s, with a minimum for miR-291b (less than
1/10 of the Sno243 level) and a maximum for miR-295.
For the moment we can only speculate on these
discrepancies as reﬂecting the differences in the turnover
of the miR290s, since microRNA stability has been shown
to be an important component of microRNA homeostasis
(15,16). However, the expression of all miRs is gradually
attenuated along ESCs differentiation (e.g. towards neural
progenitor cells, NPC), becoming negligible in MEF
(Figure 1A and B).
An intragenic enhancer within the EEmiR cluster
In an attempt to ﬁnd novel regulatory sequences govern-
ing the transcription of EEmiRC locus, we examined the
genomic region separating the two hemiclusters. We found
that two partially overlapping inter-hC DNA fragments,
namely En-II (from+1419 to+2205, overlapping with the
pre-miR291b locus) and En-II-4 (from +1828 to +2205)
are able to drive Luciferase transcription when cloned in a
pGL-4.23 vector, with En-II activity being signiﬁcantly
higher than En-II-4. In strong contrast, an En-I
fragment (from  3423 to  240) covering a region previ-
ously shown to harbor Oct-4/Sox2 active binding sites (2)
failed to activate luciferase transcription when cloned into
the same vector (Figure 2A and B). Furthermore, the
En-II fragment was not able to activate Luciferase tran-
scription when cloned into a promotor-less vector pGL-
4.23dMP, indicating enhancer activity. Deletion analysis
of En-II ultimately led to the identiﬁcation of a 332bp
fragment En-II.1a (from +1419 to +1751) able to drive
Luciferase transcription with the same efﬁciency as the
entire En-II fragment when expressed from a pGL-4.23
construct driven by a minimal promoter in either
HEK293T, mouse ESCs or P19CL6 undifferentiated em-
bryonal carcinoma cells (Figure 2B). Experiments per-
formed in ESCs showed that when cloned downstream
of the Luciferase in a pGL-4.23dMP-miR290-Pro vector,
the En-II-1.a fragment is able to interact with and enhance
the transcription from the upstream endogenous EEmiRC
promoter (Figure 2C). Further more, in order to mimic
the in vivo context of the EEmiR Cluster, we have deleted
En-II.1.a from a pEEmiRC (7) construct holding a
EGFP-tag fused downstream of miR295 and found a sig-
niﬁcant decrease in the level of EGFP transcripts, further
suggesting that the 332bp fragment is required for
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(Figure 2D).
We noticed that the luciferase activity readings were
consistently higher in ESCs and P19CL6 experiments
compared to the HEK293T ones (Figure 2B), suggesting
that En-II.1a transcriptional activity beneﬁts from the
presence of pluripotency factors in ESCs and P19CL6
cells. This hypothesis would be in concordance with data
showing that the decrease in the expression of pluripotency
factors Oct3/4 and Nanog during ESC differentiation cor-
relates with the decrease in miR290s expression (Figure 1A
and B) (7). Of note, Marson et al. (2) described Oct3/4,
Nanog and Sox2 ChIP-enrichment 50-upstream of the
transcription initiation site of the EEmiRC, but not
within the cluster. Since the construct lacking the
En-II.1a (pEEmiRC-dEnII.1a-EGFP) expresses the
EGFP at signiﬁcantly lower levels when transfected into
mESCc (Figure 2D), we were interested in understanding
the mechanisms by which En-II.1a exerts its effects upon
EEmiRC transcription.
Binding of Oct-3/4, Sox2 and CTCF is enriched at the IE
We asked whether the En-II.1a or its vicinity is occupied
by factors currently known to modulate pluripotency.
ChIP analysis of the genomic region separating the two
hCs showed a signiﬁcant enrichment in binding events for
Oct3/4, Sox2 and CCCTC-binding factor (CTCF) in two
speciﬁc domains: within the En-II.1a (designated P3) and
30 of En-II.1a (designated P4) (Figure 3). Surprisingly, the
DNA regions upstream (P1) and downstream (P2) of the
transcription initiation site show a much lower level of
occupancy as it might have been anticipated from previ-
ously published Oct3/4 and Sox2 genome-wide ChIP ex-
periments (3). Consistent with previous data showing that
Oct3/4 cooperates with Sox2 and CTCF to drive tran-
scription of target genes (11,17,18), the level of occupancy
of both P3 and P4 domains gradually and dramatically
decreases during ESC differentiation, suggesting a func-
tional role for these transcription factors in regulating
EEmiRC expression (Figure 3). Within the inter-hC
region (overlapping En-II and En-II-4), the binding sites
for Oct4, Sox2 and CTCF are situated in close proximity,
suggesting a cooperative mode of action (Supplementary
Figure S1). Furthermore, Oct3/4 appears to coordinate
the recruitment of both Sox2 and CTCF to P3 and P4
regions, as the occupancy for these factors is strongly
reduced in doxycycline-inducible Oct3/4-knockout
ESCs (ZHBTc4; 13) upon addition of doxycycline
(Figure 3F–H), while the total protein levels of Sox2 and
CTCF are minimally changed (Supplementary Figure S2).
Epigenetic marks at the EEmiRC IE
A characteristic of the genes responsible for early devel-
opment of the embryos is their ambivalent epigenetic
signature, i.e. associate both repressive marks (like
H3K27me3) and active marks (like H3K4me3), suggestive
for a ready-to-transcribe status of these genes in the highly
dynamic chromatin context of pluripotent cells (19). Many
of the ambivalently marked chromatin regions also
associate binding-enrichment of Oct4/Sox2 transcription
factors (20) while Sox2 has been shown to directly
activate histone demethylases involved in ESC self-
renewal (21,22). CTCF has an ambivalent role. CTCF
binding sites have been shown to be associated to
H3K27me3-marked chromatin domains (23,24); CTCF
is also supposed to protect unmethylated CpG-containing
DNA regions from silencing through DNA methylation
by blocking PARP1-Dnmt1 crosstalk (25). We have there-
fore asked whether En-II.1a also associates epigenetic
marks like DNA methylation and histone-3 methylation.
Bioinformatics analysis of the EEmiRC locus revealed
the presence of 12 CG repeats in a 222bp CpG island
within the En-II.1.a (Supplementary Figure S1). We
have analyzed the methylation status of this CpG island
by bisulphate sequencing and found that the decrease in
miR2900s expression during ESCs differentiation associ-
ates a progressive methylation of the 12 CG-repeats. To
conﬁrm the functional role of the CpG island, we
Figure 1. Expression of members of the miR-290s and pluripotency factors gradually decreases during E14.1 ES cells differentiation.
(A) Quantitative RT–PCR analysis of EEmiRC miRs in ES (black bar), neural progenitor cell at Day 4 of differentiation (NPCD4) (white),
neural progenitor cell at Day 8 of differentiation NPCD8 (gray) and MEFs (white/gray); expression levels were normalized relative to Sno234.
(B) Expression levels of Oct-3/4 and Nanog (relative to Histone4, H4) in ES, NPCD4, NPCD8 and MEF’s. Data are represented as means±SEM of
at least three independent experiments. *P<0.05; **P<0.01.
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construct using the CpG methyltransferase M.SssI (26),
and found a strong decrease of Luciferase activity
after methylation of the pGL-4.23-En-II.1a vector
(Figure 4C and Supplementary Figure S3). Conversely,
culturing MEFs in the presence of the demethylating
agent 5-azacytidine (27) partially restored the expression
of EEmiRC; this effect that was further enhanced by the
addition of histone deacetylase inhibitor Trychostatin
A (TSA) (Figure 4D), a synergistic effect previously
shown to resuscitate the transcription of epigenetically
silenced genes (28,29). Of note, in our assay, miR-291b
expression cannot be restored either by 5-Aza, TSA nor
by the combination of the two compounds. ChIP analysis
of the P3 and P4 domains of the inter-hCs region
shows that the H3K4me3 (30) enrichment found in
ESCs is gradually lost during differentiation in favor of
silencing marks like H3K27me3 (31), further proving that
the region is subjected to heavy epigenetic regulation
(Figure 4E and F).
Figure 2. Identiﬁcation of En-II.1a enhancer within the EEmiR cluster. (A) Schematic representation of genomic regions used in the luciferase
reporter assays; nucleotide positions are relative to the EEmiRC transcriptional start site. The different genomic regions of the inter-hC were cloned
in to pGL-4.23 and pGL-4.23dMP (without the minimal promoter) vector and tested for the ability to promote luciferase transcription after
transfection in HEK293T, mESCs and P19CL6 cells. (B) Delineation of the inter-hC enhancer using deletion constructs. The 332bp fragment
(En-II.1a) shows signiﬁcant enhancer activity in HEK293T, mESCs and P19CL6 cells. (C) The En-II.1.a fragment cloned downstream of
Luciferase enhances transcription from the endogenous miR290 promoter in a pGL-4.23dMP vector transfected in mESCs. Data are normalized
to pGL-4.23dMP readings and represented as mean±SD from three different experiments. (D) Deletion of En-II.1a signiﬁcantly reduces the level of
expression of EGFP from a pEEmiRC-EGFP construct transfected into mESCs. Data are normalized to Renilla transcripts and represented as
mean±SD from three different experiments. *P<0.05; **P<0.01.
Nucleic Acids Research,2011, Vol.39, No. 9 3577Figure 3. En-II.1a and its vicinity are highly enriched in Oct3/4, Sox2 and CTCF. (A) Schematic representation of the EEmiRC genomic regions
(P1–P4) subjected to ChIP-qPCR analysis. P3 and P4 are highly enriched in Oct3/4 (B), Sox2 (C) and CTCF (D) when compared to IgG control (E).
Doxycyclin-induced depletion of Oct3/4 in ZHBTc4 ES cells strongly reduces the recruitment of Sox2 (F) and CTCF (G) to P3 and P4 regions when
compared to IgG controls (H). Data are represented as mean±SD from three different experiments. *P<0.05; **P<0.01; ***P<0.001.
3578 Nucleic Acids Research, 2011,Vol.39, No. 9Figure 4. En-II.1a enhancer is subject to epigenetic regulation. (A) Schematic representation of the 222bp CpG island within the inter-hC region.
(B) DNA methylation analysis of the 12 CG dinucleotides of the CpG island in ES, NPCD4, NPCD8 and MEFs using the bisulphite-sequencing
approach. Each column represents a CpG dinucleotide, each row represents the number of clones analysed. Open circles represents the
unmethylated CpGs, closed circles represents the methylated CpGs. (C) In vitro methylation of pGL-4.23-En-II.1a construct using M.SssI leads
to a loss of the enhancer activity as assesed by luciferase assay. The enhancer activities were normalized to M.SssI-treated and -untreated empty
vectors and represented as relative luciferase units (RLU). (D) Treatment of MEFs with the DNA methyltransferase inhibitor 50-azacytidine
(50-azaC), HDAC inhibitor trichostatin A (TSA) or a combination of both reactivates the expression of the members of the EEmiRC.
(E and F) ChIP–qPCR analysis of P1–P4 enrichment in H3K4 (E) and H3K27 (F) trimethylation in ESCs (black bar), NPCD4 (white bar),
NPCD8 (gray bar) and MEFs (white/gray bar). Data in (C–F) are represented as mean±SD from three different experiments. *P<0.05;
**P<0.01; ***P<0.001.
Nucleic Acids Research,2011, Vol.39, No. 9 3579DISCUSSION
EEmiRC represent not only the majority (over 70%) of
the microRNAs in ESCs (6), but also one of the
best-characterized (so far) ES-speciﬁc miRNAs: it
promotes proliferation of ESCs by regulating G1-S tran-
sition (8), controls de novo DNA methylation (including
Oct3/4 promoter) (9,10) and enhances the ability of
Oct3/4, Sox2 and Klf4 to re-programme MEFs (12).
Genome-wide ChIP experiments suggested that EEmiRC
expression is controlled by Oct3/4 (3) through binding
(together with other pluripotency factors like Sox2 and
Nanog) to the promoter region (2,11), which also bears
histone methylation marks: H3K4-me3 (activation mark)
in ESCs and H3K27me3 (repressive mark) in
differentiated cells (17).
Our study shows that an intragenic enhancer (IE)
residing in the inter-hC region and not only the
EEmiRC promoter is required for the integration of
miR290s in the ESCs speciﬁc auto-regulatory circuit.
The binding events to IE of all the transcription factors
used in our work (Oct3/4, Sox2, CTCF) are much more
abundant when compared to the region comprising the
putative EEmiRC promoter as deﬁned by previous
studies (2,7,12). Our in silico analysis suggests that these
TF binding sites are densely clustered in two regions at the
50 and 30 of the inter-hC region, implying an extensive
local inter-cooperativity. Therefore, the EEmiRC inter-
hC region harbors a multiple transcription factor-
binding locus with ESC enhancer activity (12), in which
the recruitment of TFs (and most probably their subse-
quent transcriptional synergy) is governed by Oct3/4. We
have also shown that in ESCs, Oct4/Sox2/CTCF cluster-
ing to inter-hC associates H3K4me3 mark characteristic
for active genomic regions, thus portraying the IE as a
bona ﬁde ESC-speciﬁc enhanceosome as described by
Chen and colleagues (12). From this point of view, it
would be interesting to analyze the functional signiﬁcance
and hierarchy of occupancy for all the TFs predicted
to bind to the IE, including the functionally versatile
CCCTC-binding factor, CTCF (32).
The cross-talk between microRNAs and the epigenetic
effectors has lately received considerable attention, since
its perturbation has been shown to be associated with ma-
lignant characteristics of tumors in humans (33). miR290s
have been shown to be modulators of epigenetic machin-
ery (9,10), but the epigenetic control of their expression
has been only marginally investigated (12). Our data show
that IE confers epigenetic sensitivity to EEmiRC through
both histone modiﬁcations and the methylation of a novel
CpG island within the En-II.1a. As a rule of thumb, the
promoters and enhancers of pluripotency associated
factors are hypomethylated in ESCs (but hypermethylated
in their differentiated derivatives) and associate H3K3
trimethylation (progressively replaced by H3K27
trimethylation during differentiation) (34,35). In this
respect, the epigenetic signature of IE in EEmiRC makes
no exception from the rule, being similar to that of Oct3/4
(36) or Nanog (37): is CpG hypomethylated and associates
H3K4me3 in pluripotent ESCs and CpG hypermethylated
and associates H3K27me3 in differentiated NPCs.
Therefore, the EEmiRC-IE allows the Dnmts to nega-
tively feed back on EEmiRC and functionally close a
feedback loop with effects on the level of miR290s expres-
sion. However, since the effect of miR290s on Dnmts has
been shown to be speciﬁc to ESC behavior (10), we suggest
that this negative feedback loop is governed by
pluripotency factors such as Oct3/4 and Sox2.
By integrating inputs from Oct3/4, Sox2 and CTCF
with epigenetic cues (through methylation of the CpG
island and association with histone3 methylation marks),
the EEmiRC-IE represents the module required for the
insertion of the miR290s into the complex stem cells-
speciﬁc regulatory circuit of pluripotency factors,
epigenetic mechanisms and microRNAs (38).
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